Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
204,318,397
-
Share change
-
-5,761,676
-
Total reported value
-
$90,784,164,128
-
Put/Call ratio
-
88%
-
Price per share
-
$444.29
-
Number of holders
-
1,490
-
Value change
-
-$2,610,836,696
-
Number of buys
-
664
-
Number of sells
-
663
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2023
As of 30 Jun 2023,
Elevance Health, Inc. - Common Stock (ELV) was held by
1,490 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
204,318,397 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Capital International Investors, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, Sanders Capital, LLC, and AMERIPRISE FINANCIAL INC.
This page lists
1,512
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.